Collin M. Blakely, Ph.D.
Affiliations: | 2006 | University of Pennsylvania, Philadelphia, PA, United States |
Area:
Molecular Biology, Cell Biology, Oncology, Public HealthGoogle:
"Collin Blakely"Cross-listing: PHTree
Parents
Sign in to add mentor| Lewis A. Chodosh | grad student | 2006 | Penn | |
| (Developmental events influence breast cancer risk: Insights from MYC, Stat5, and pregnancy.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Sinha S, Vegesna R, Mukherjee S, et al. (2024) PERCEPTION predicts patient response and resistance to treatment using single-cell transcriptomics of their tumors. Nature Cancer |
| Lara MS, Blakely CM, Riess JW. (2024) Targeting MEK in non-small cell lung cancer. Current Problems in Cancer. 101065 |
| Caswell DR, Gui P, Mayekar MK, et al. (2023) The role of APOBEC3B in lung tumor evolution and targeted cancer therapy resistance. Nature Genetics |
| He K, Berz D, Gadgeel SM, et al. (2023) MRTX-500 Phase 2 Trial: Sitravatinib With Nivolumab in Patients With Non-Squamous Non-Small Cell Lung Cancer Progressing On/After Checkpoint Inhibitor Therapy or Chemotherapy. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer |
| Noronha A, Belugali Nataraj N, Sang Lee J, et al. (2022) AXL and error-prone DNA replication confer drug resistance and offer strategies to treat EGFR-mutant lung cancer. Cancer Discovery |
| Nanjo S, Wu W, Karachaliou N, et al. (2022) Deficiency of the splicing factor RBM10 limits EGFR inhibitor response in EGFR mutant lung cancer. The Journal of Clinical Investigation |
| Ali M, Lu M, Ang HX, et al. (2022) Small-molecule targeted therapies induce dependence on DNA double-strand break repair in residual tumor cells. Science Translational Medicine. 14: eabc7480 |
| Barbosa Rabago D, Blakely CM, Haderk F, et al. (2021) Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids. Journal of Visualized Experiments : Jove |
| Maynard A, McCoach CE, Rotow JK, et al. (2020) Therapy-Induced Evolution of Human Lung Cancer Revealed by Single-Cell RNA Sequencing. Cell |
| Gini B, Thomas N, Blakely CM. (2020) Impact of concurrent genomic alterations in epidermal growth factor receptor ()-mutated lung cancer. Journal of Thoracic Disease. 12: 2883-2895 |